powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1932461548
Michael Rey
M.D.
Pulmonary Disease
Philadelphia,
PA
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
QUALITY · MIPS · 2024
Final MIPS score
84.9
Quality
73.6
Cost
76.1
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.42%
Group
PRESCRIBING · PART D · 2024
Total Rx claims
856
Beneficiaries
—
Total drug cost
$2.5M
Distinct drugs
30
Brand share
43.6%
Top prescribed drugs
Azithromycin
74 claims
Elexacaftor/Tezacaftor/Ivacaft
71 claims
Montelukast Sodium
70 claims
Prednisone
59 claims
Fluticasone Propionate
56 claims
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
327
Unique beneficiaries
—
Total services
481
Distinct HCPCS
6
Medicare payment
$31K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 571 Pulmonary Disease providers in PA — below median (cohort median 707).